Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Serigne Lo; Angela Hong; Lauren E. Haydu; Tasnia Ahmed; Elizabeth Paton; Victoria Steel; George Hruby; Anh Tran; Rachael L. Morton; Anna K. Nowak; Janette L. Vardy; Katharine J. Drummond; Haryana M. Dhillon; Catherine Mandel; Richard A Scolyer; Mark R. Middleton; Bryan Burmeister; John F. Thompson; Gerald B. Fogarty

doi:10.1186/s13063-019-3555-5

Article2019

Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).

Gerald B. Fogarty, Kari Dolven-Jacobsen, Rachael L. Morton, George Hruby, Anna K. Nowak, Janette L. Vardy, Katharine J. Drummond, Haryana M. Dhillon, Catherine Mandel, Richard A Scolyer, Brindha Shivalingham, Mark R. Middleton, Bryan Burmeister, Serigne Lo, Claudius H. Reisse, Elizabeth Paton, Victoria Steel, Narelle Williams, John F. Thompson, Angela Hong

Article2019

Neurocognitive outcomes in a phase-3 randomised trial comparing adjuvant whole brain radiotherapy with observation after local treatment of brain metastases in patients with melanoma

Haryana M. Dhillon, Gerald B. Fogarty, Kari Dolven-Jacobsen, Rachael L. Morton, George Hruby, Anna K. Nowak, Janette L. Vardy, Kate Drummond, Catherine Mandel, Richard A Scolyer, Brindha Shivalingam, Mark R. Middleton, Bryan Burmeister, Daniel Roos, Serigne Lo, Claudius H. Reisse, Elizabeth Paton, Narelle Williams, John F. Thompson, Angela Hong

Article2021

Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group

Elise Lavit, Mihaela Aldea, Sophie Piperno‐Neumann, Nelly Firmin, Antoîne Italiano, Nicolás Isambert, Jean‐Emmanuel Kurtz, Corinne Delcambre, V. Lebrun, Pauline Soibinet‐Oudot, Christine Chevreau, Emmanuelle Bompas, Christine Le Maignan, Pascaline Boudou‐Rouquette, Axel Le Cesne, Julien Mancini, Jean Yves Blay, Florence Duffaud

Preprint2023

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

James S. Wilmott, Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A. Vergara, Hansol Lee, Peter A. Johansson, Peter M. Ferguson, Philippe Saïag, Caroline Robert, Jean‐Jacques Grob, Lisa H. Butterfield, Richard A Scolyer, John M. Kirkwood, Georgina V. Long, Michael A. Davies

Preprint2023

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

James S. Wilmott, Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A. Vergara, Hansol Lee, Peter A. Johansson, Peter M. Ferguson, Philippe Saïag, Caroline Robert, Jean‐Jacques Grob, Lisa H. Butterfield, Richard A Scolyer, John M. Kirkwood, Georgina V. Long, Michael A. Davies

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Abstract

Discussion(0)

Related publications

Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).

Neurocognitive outcomes in a phase-3 randomised trial comparing adjuvant whole brain radiotherapy with observation after local treatment of brain metastases in patients with melanoma

Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases